SuppreMol
Development of new therapies for autoimmune diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD340m (Public information from Mar 2015)
Company register number HRB 189428 B (Charlottenburg (Berlin))
Planegg Bavaria (HQ)
Authorizing premium user...